<!doctype html><html lang="zh-hans"><head><meta charset="utf-8"><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"><title>FDA说，调整COVID疫苗以对抗变体不需要大的试验 Tweaking COVID vaccines to fight variants won’t require big trials, FDA says</title><link rel="stylesheet" href="https://stackpath.bootstrapcdn.com/bootstrap/4.3.1/css/bootstrap.min.css" integrity="sha384-ggOyR0iXCbMQv3Xipma34MD+dH/1fQ784/j6cY/iJTQUOhcWr7x9JvoRxT2MZw1T" crossorigin="anonymous"><link rel="stylesheet" href="/img/css.css?random="><link data-rh="true" rel="icon" href="/img/favicon.ico"/><script data-ad-client="ca-pub-6067137220025946" async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script><script type="text/javascript" src="https://platform-api.sharethis.com/js/sharethis.js#property=5effb96910009800120b8d4d&product=inline-share-buttons" async="async"></script>
<script>var _hmt = _hmt || [];(function() {var hm = document.createElement("script");hm.src = "https://hm.baidu.com/hm.js?03c1a0f31299b4a2fbb83c34d6beaac9";var s = document.getElementsByTagName("script")[0]; s.parentNode.insertBefore(hm, s);})();</script></head><body><div id="my_header"><div class="container"><nav class="navbar navbar-expand-lg"><a class="navbar-brand" href="/"><img alt="diglog" src="/img/logo.v1.gif" class="rounded-sm"></a><button class="navbar-toggler" type="button" data-toggle="collapse" data-target="#navbarNavAltMarkup" aria-controls="navbarNavAltMarkup" aria-expanded="false" aria-label="Toggle navigation"><span class="navbar-toggler-icon"></span></button><div class="collapse navbar-collapse" id="navbarNavAltMarkup"><div class="navbar-nav"></div></div></nav></div></div><div class="container"><div id="my_content"><h1 class="page_narrow">Tweaking COVID vaccines to fight variants won’t require big trials, FDA says<br/>FDA说，调整COVID疫苗以对抗变体不需要大的试验 </h1><div class="row"><div class="col-lg-12 col-12"><div class="my_story_list_item shadow p-3 mb-5 bg-white rounded"><div class="story_page_pub_time page_narrow">2021-02-06 20:59:16</div><div class="story_img_container"><a href="http://img2.diglog.com/img/2021/2/6b010288b7e3ffaeea0bc744794bd455.jpg"><img src="http://img2.diglog.com/img/2021/2/6b010288b7e3ffaeea0bc744794bd455.jpg" class="img-fluid my_story_img" onerror="this.style.display='none'"></a></div><div class="page_narrow text-break page_content"><p>With concerning coronavirus variants erupting around the world, the US Food and Drug Administration is ironing out how to rapidly review vaccine tweaks that better protect against the mutants—and the regulatory agency is turning to its experience with annual flu shots to do so.</p><p>随着全球范围内爆发冠状病毒变种，美国食品药品监督管理局（FDA）正在努力解决如何快速审查可更好地保护其免受突变影响的疫苗调整的问题，而监管机构正在利用其在年度流感预防针上的经验来做到这一点。</p><p> In a  statement late Thursday, the regulatory agency said it is actively hashing out what kind of “streamlined” clinical data makers of authorized COVID-19 vaccines could submit. The agency expects to have a draft of its guidance in the next few weeks.</p><p> 在周四晚些时候的一份声明中，该监管机构表示，正在积极计算授权的COVID-19疫苗可以提交什么样的“精简”临床数据制作者。该机构预计将在未来几周内制定其指南草案。</p><p> The announcement suggests that makers of authorized vaccines will not be required to submit reams of data from large, months-long clinical trials, as they did for their initial authorizations. Still, data on any altered vaccine—however pared down—would still have to be enough to convince FDA scientists that a next-generation shot is safe and effective against variants. Vaccine alterations may include changes to the initial vaccine design or additions of new vaccine components, the FDA said.</p><p> 该公告表明，授权疫苗的生产商将不需要像最初授权那样提交大量的，长达数月的大型临床试验数据。尽管如此，任何经过改变的疫苗的数据（无论如何减少）仍将足以说服FDA的科学家，下一代疫苗对变种是安全有效的。 FDA说，疫苗变更可能包括对初始疫苗设计的更改或新疫苗成分的添加。</p><p> So far, the FDA has issued emergency use authorizations for two COVID-19 vaccines, an mRNA-based vaccine made by Moderna and another by partners Pfizer and BioNTech. (The FDA is now reviewing an EUA application for  a third candidate, made by Johnson &amp; Johnson, which is a non-replicating adenovirus-based vaccine.) Both mRNA vaccines showed around 95 percent efficacy in massive international Phase III trials. However, those trials were conducted prior to the rise of concerning variants, some of which appear to be able to evade immune responses. Early clinical data does indeed suggest that vaccine efficacy will be reduced by the currently emerging variants—though not eliminated entirely.</p><p> 到目前为止，FDA已发布了两种COVID-19疫苗的紧急使用授权，一种是Moderna生产的基于mRNA的疫苗，另一种是合作伙伴辉瑞和BioNTech生产的。 （FDA现在正在审查由Johnson＆amp; Johnson制造的第三种候选药物的EUA申请，这是一种非复制型基于腺病毒的疫苗。）这两种mRNA疫苗在大规模的国际III期临床试验中显示出约95％的功效。但是，这些试验是在相关变体出现之前进行的，其中一些变体似乎能够逃避免疫反应。确实，早期的临床数据确实表明，疫苗的功效会因目前出现的变异而降低，尽管不能完全消除。</p><p>    The FDA emphasized this last point, writing, “To be clear, while we continue to develop an understanding of and address any impact of variants on FDA-regulated products, at this time, available information suggests that the authorized vaccines remain effective in protecting the American public against currently circulating strains of COVID-19.”</p><p>    FDA强调了最后一点，写道：“要明确，尽管我们继续发展理解并解决变体对FDA管制产品的任何影响，但是，目前的信息表明，授权疫苗仍可以有效地保护疫苗的安全。美国公众反对目前正在传播的COVID-19毒株。”</p><p>  But it’s also clear that the pandemic coronavirus, SARS-CoV-2, is continuing to evolve, becoming more transmissible and able to evade immune responses. We’re likely to continue to see concerning variants arise. &#34;We must prepare for all eventualities,&#34; FDA&#39;s acting Commissioner Janet Woodcock, said on a call with reporters.</p><p>  但也很明显，大流行冠状病毒SARS-CoV-2正在继续发展，变得更具传播性，并且能够逃避免疫反应。我们可能会继续看到有关变体的问题。 ＆＃34;我们必须为所有可能发生的事情做好准备，＆＃34; FDA代理专员Janet Woodcock在与记者的电话中说。</p><p> To prepare and develop its new guidance, the agency is drawing on its experience with annual flu shots. “Influenza vaccines and diagnostics are often modified each year to address the predicted predominant strains circulating globally. The agency has created and used regulatory processes that facilitate these updates,” the agency wrote. “We will utilize our experience with influenza to help inform a path forward if SARS-CoV-2 variants emerge against which currently authorized vaccines are not sufficiently effective.”</p><p> 为了准备和制定新指南，该机构正在利用其在年度流感预防针方面的经验。 “流感疫苗和诊断方法经常每年进行修改，以解决全球范围内预测的主要菌株。该机构已经创建并使用了促进这些更新的监管流程，”该机构写道。 “我们将利用我们在流感方面的经验，为出现SARS-CoV-2变体提供信息，这对目前授权的疫苗还不够有效。” </p><p> Moderna, Pfizer, and BioNTech have all said they are looking into tweaking their current vaccines to better protect against emerging variants. Their mRNA-based vaccine designs make this a relatively easy process. The vaccine works by delivering to human cells the genetic blueprint for a key SARS-CoV-2 protein—the spike protein. From there, the cells translate the code into protein, which then trains the immune system to detect and neutralize the virus.</p><p>Moderna，辉瑞和BioNTech都表示，他们正在研究调整当前的疫苗，以更好地防御新出现的变异。他们基于mRNA的疫苗设计使这一过程相对容易。该疫苗通过向人体细胞传递关键SARS-CoV-2蛋白（即刺突蛋白）的遗传蓝图而发挥作用。细胞从那里将代码翻译成蛋白质，然后训练免疫系统以检测和中和病毒。</p><p> The variants seen so far have critical mutations in their spike proteins, so updating the vaccines is mostly a matter of making small changes to the blueprint delivered to cells. BioNTech’s CEO has previously said that the company could carry out such tweaking in just  six weeks.</p><p> 迄今为止发现的变体在其刺突蛋白中具有关键突变，因此更新疫苗主要是对传递至细胞的蓝图进行小改动。 BioNTech的首席执行官此前曾表示，该公司可以在短短六周内进行这种调整。</p><p> Similarly, GlaxoSmithKline announced this week that it has partnered with German biotech firm CureVac to help bring its mRNA-based vaccine to market—and begin work on  the next-generations of the vaccine to protect against variants. GSK and CureVac said they are working on developing a “multivalent” mRNA-based vaccine that could potentially protect against multiple variants at the same time.</p><p> 同样，葛兰素史克本周宣布，它已与德国生物技术公司CureVac合作，将其基于mRNA的疫苗推向市场，并开始研发下一代疫苗以防止变种。 GSK和CureVac表示，他们正在开发一种基于“多价”基于mRNA的疫苗，该疫苗可能同时针对多种变体提供保护。 </p></div><div id="story_share_this"><div class="sharethis-inline-share-buttons"></div></div><div class="text-break sotry_link page_narrow"><a target="_blank" href="https://arstechnica.com/science/2021/02/tweaking-covid-vaccines-to-fight-variants-wont-require-big-trials-fda-says/">https://arstechnica.com/science/2021/02/tweaking-covid-vaccines-to-fight-variants-wont-require-big-trials-fda-says/</a></div><div class="story_tags page_narrow"><button type="button" class="btn btn-light my_tag"><a href="/tag/对抗/">#对抗</a></button><button type="button" class="btn btn-light my_tag"><a href="/tag/covid/">#covid</a></button><button type="button" class="btn btn-light my_tag"><a href="/tag/疫苗/">#疫苗</a></button></div></div><div class="my_movie_list_item shadow p-3 mb-5 bg-white rounded"><button type="button" class="btn btn-link my_tag"><a href="/tag/web2.0/">#web2.0</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/google/">#google</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/设计/">#设计</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/创意/">#创意</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/摄影/">#摄影</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/游戏/">#游戏</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/图片/">#图片</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/软件/">#软件</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/视频/">#视频</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/手机/">#手机</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/广告/">#广告</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/iphone/">#iphone</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/网站/">#网站</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/免费/">#免费</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/下载/">#下载</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/windows/">#windows</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/微软/">#微软</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/苹果/">#苹果</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/apple/">#apple</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/blog/">#blog</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/firefox/">#firefox</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/音乐/">#音乐</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/博客/">#博客</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/wordpress/">#wordpress</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/恶搞/">#恶搞</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/qq/">#qq</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/艺术/">#艺术</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/web/">#web</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/工具/">#工具</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/分享/">#分享</a></button></div></div></div><div id="my_footer"><div class=""><a href="/tags/">tags</a> <a href="/users/">users</a></div>&copy; 2020 diglog.com </div></div></body></html>